<?xml version="1.0" encoding="utf-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Actinium Pharmaceuticals, Inc. </title><link>https://investorshangout.com/Actinium-Pharmaceuticals-Inc-ATNM-87773/</link><description><![CDATA[Actinium Pharmaceuticals, Inc.  (ATNM)]]></description><language>en-us</language><pubDate>Mon, 21 Sep 2026 23:59:31 GMT</pubDate><copyright>Copyright InvestorsHangout.com</copyright><atom:link href="https://investorshangout.com/Actinium-Pharmaceuticals-Inc-ATNM-87773/" rel="self" type="application/rss+xml"/><item><title>whytestocks: $ATNM News Article - Actinium Announces Acceptance of Five Abstracts for Presentation at the 2024 Ta</title><link>https://investorshangout.com/post/view?id=6659056</link><guid>https://investorshangout.com/post/view?id=6659056</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 02 Jan 2024 16:25:55 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharma to Present at the Maxim Healthcare Virtual Conference </title><link>https://investorshangout.com/post/view?id=6586703</link><guid>https://investorshangout.com/post/view?id=6586703</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 16 Jun 2023 17:15:47 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Dr. Sergio Giralt to Discuss Positive Result</title><link>https://investorshangout.com/post/view?id=6541883</link><guid>https://investorshangout.com/post/view?id=6541883</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 27 Feb 2023 13:05:46 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Appoints Seasoned Leader Caroline Yarbrough as Chief Commercial Office</title><link>https://investorshangout.com/post/view?id=6492826</link><guid>https://investorshangout.com/post/view?id=6492826</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 02 Nov 2022 12:25:53 GMT</pubDate></item><item><title>znewcar1: $ATNM 39% v8,6M C13.54 f25,2M H13.89 nice</title><link>https://investorshangout.com/post/view?id=6492137</link><guid>https://investorshangout.com/post/view?id=6492137</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 01 Nov 2022 02:10:24 GMT</pubDate></item><item><title>znewcar1: $ATNM 29% v3M c12.62 f25,184M H12.74 LL4.41 ML6.78 getting into clear skies. </title><link>https://investorshangout.com/post/view?id=6491909</link><guid>https://investorshangout.com/post/view?id=6491909</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 31 Oct 2022 16:54:14 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Why Is Getty Images (GETY) Stock Up 33% Today? </title><link>https://investorshangout.com/post/view?id=6491894</link><guid>https://investorshangout.com/post/view?id=6491894</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 31 Oct 2022 16:35:54 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium (ATNM) Stock Pops on Positive Trial Results </title><link>https://investorshangout.com/post/view?id=6491869</link><guid>https://investorshangout.com/post/view?id=6491869</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 31 Oct 2022 15:55:50 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Announces Positive Top-line Results from Pivotal Phase 3 SIERRA Trial </title><link>https://investorshangout.com/post/view?id=6491750</link><guid>https://investorshangout.com/post/view?id=6491750</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 31 Oct 2022 13:50:50 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals to Participate in the 2022 Bio-Europe Conference </title><link>https://investorshangout.com/post/view?id=6489743</link><guid>https://investorshangout.com/post/view?id=6489743</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 26 Oct 2022 15:15:55 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Bolsters its Senior Leadership Team Ahead of Upcoming Clinical Data fo</title><link>https://investorshangout.com/post/view?id=6489275</link><guid>https://investorshangout.com/post/view?id=6489275</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 25 Oct 2022 16:21:11 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Iomab-B SIERRA Trial Database Lock, Provides</title><link>https://investorshangout.com/post/view?id=6474002</link><guid>https://investorshangout.com/post/view?id=6474002</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 21 Sep 2022 15:09:46 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals, Inc. and Immedica Announce Commercialization Agreemen</title><link>https://investorshangout.com/post/view?id=6381953</link><guid>https://investorshangout.com/post/view?id=6381953</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 12 Apr 2022 14:25:54 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals Highlights Potent Anti-Tumor Activity of a HER3 Target</title><link>https://investorshangout.com/post/view?id=6381436</link><guid>https://investorshangout.com/post/view?id=6381436</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 11 Apr 2022 19:50:51 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals Presents Preclinical Data at AACR Showing HER3 Targete</title><link>https://investorshangout.com/post/view?id=6381428</link><guid>https://investorshangout.com/post/view?id=6381428</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 11 Apr 2022 19:40:50 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Announces Several Presentations from the Phase 3 SIERRA Study of Iomab</title><link>https://investorshangout.com/post/view?id=6151736</link><guid>https://investorshangout.com/post/view?id=6151736</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 03 Jun 2021 20:15:51 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Strengthens Leadership Team with Appointment of Dr. Avinash Desai as E</title><link>https://investorshangout.com/post/view?id=5967544</link><guid>https://investorshangout.com/post/view?id=5967544</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 19 Nov 2020 14:51:08 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - 100% Remission Rate Reported in Third Dose Cohort of Actimab-A CLAG-M Phase 1 C</title><link>https://investorshangout.com/post/view?id=5951930</link><guid>https://investorshangout.com/post/view?id=5951930</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 04 Nov 2020 17:40:48 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Promising New Cancer Treatments Advancing Through The Pipeline In Over $200 Bil</title><link>https://investorshangout.com/post/view?id=5937603</link><guid>https://investorshangout.com/post/view?id=5937603</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 21 Oct 2020 15:00:47 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals, Inc. Expands R&amp;D Capabilities with New Research Facil</title><link>https://investorshangout.com/post/view?id=5929663</link><guid>https://investorshangout.com/post/view?id=5929663</guid><description><![CDATA[whytestocks
]]></description><pubDate>Wed, 14 Oct 2020 17:35:50 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Pharmaceuticals Announces Successful Completion of Planned Phase 1 Act</title><link>https://investorshangout.com/post/view?id=5892508</link><guid>https://investorshangout.com/post/view?id=5892508</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 14 Sep 2020 12:25:48 GMT</pubDate></item><item><title>EmergingGrowth: ATNM https://emerginggrowth.com/could-covid-19-concerns-be-helping-to-drive-sales-of-glucose-heal</title><link>https://investorshangout.com/post/view?id=5856223</link><guid>https://investorshangout.com/post/view?id=5856223</guid><description><![CDATA[EmergingGrowth
]]></description><pubDate>Tue, 11 Aug 2020 13:35:19 GMT</pubDate></item><item><title>JJ Rotten: .60 pre market...Sweet!</title><link>https://investorshangout.com/post/view?id=5834700</link><guid>https://investorshangout.com/post/view?id=5834700</guid><description><![CDATA[JJ Rotten
]]></description><pubDate>Wed, 22 Jul 2020 12:19:04 GMT</pubDate></item><item><title>JJ Rotten: Moving Bobby ! wowser !</title><link>https://investorshangout.com/post/view?id=5834607</link><guid>https://investorshangout.com/post/view?id=5834607</guid><description><![CDATA[JJ Rotten
]]></description><pubDate>Wed, 22 Jul 2020 10:03:27 GMT</pubDate></item><item><title>znewcar1: ATNM 39% v93,2M c.4474 f303,3M H.53 S.4253</title><link>https://investorshangout.com/post/view?id=5791480</link><guid>https://investorshangout.com/post/view?id=5791480</guid><description><![CDATA[znewcar1
]]></description><pubDate>Tue, 09 Jun 2020 20:40:07 GMT</pubDate></item><item><title>znewcar1: ATNM 30% v80,8M c.290 f303,3M H.32 S.27</title><link>https://investorshangout.com/post/view?id=5787245</link><guid>https://investorshangout.com/post/view?id=5787245</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 04 Jun 2020 20:51:50 GMT</pubDate></item><item><title>JJ Rotten: .29/.30....Hope your still holding bob....New price target of $3.00.</title><link>https://investorshangout.com/post/view?id=5786407</link><guid>https://investorshangout.com/post/view?id=5786407</guid><description><![CDATA[JJ Rotten
]]></description><pubDate>Thu, 04 Jun 2020 12:04:31 GMT</pubDate></item><item><title>JJ Rotten: Go Baby Go.....25/26 pre market.</title><link>https://investorshangout.com/post/view?id=5786340</link><guid>https://investorshangout.com/post/view?id=5786340</guid><description><![CDATA[JJ Rotten
]]></description><pubDate>Thu, 04 Jun 2020 10:37:59 GMT</pubDate></item><item><title>znewcar1: ATNM 42% v20M c.30939 f162M H .035 S.29ish</title><link>https://investorshangout.com/post/view?id=5573988</link><guid>https://investorshangout.com/post/view?id=5573988</guid><description><![CDATA[znewcar1
]]></description><pubDate>Thu, 24 Oct 2019 20:24:20 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Announces Participation at the 2019 Cell &amp; Gene Meeting on the Mesa </title><link>https://investorshangout.com/post/view?id=5552028</link><guid>https://investorshangout.com/post/view?id=5552028</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 30 Sep 2019 15:25:42 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Announces Iomab-B Poster Selected for Honorable Distinction Award at t</title><link>https://investorshangout.com/post/view?id=5545692</link><guid>https://investorshangout.com/post/view?id=5545692</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 23 Sep 2019 13:00:51 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Achieves Fifty Percent Enrollment in the Pivotal Phase 3 SIERRA Trial </title><link>https://investorshangout.com/post/view?id=5490179</link><guid>https://investorshangout.com/post/view?id=5490179</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 23 Jul 2019 14:35:42 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Abstract Highlighting New Data from the Iomab-B Pivotal Phase 3 SIERRA Trial to</title><link>https://investorshangout.com/post/view?id=5438686</link><guid>https://investorshangout.com/post/view?id=5438686</guid><description><![CDATA[whytestocks
]]></description><pubDate>Thu, 16 May 2019 16:55:41 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium&#039;s Leading Clinical, Preclinical, Production and IP Efforts Related to </title><link>https://investorshangout.com/post/view?id=5407918</link><guid>https://investorshangout.com/post/view?id=5407918</guid><description><![CDATA[whytestocks
]]></description><pubDate>Mon, 08 Apr 2019 19:20:40 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Successfully Completes Second Module of Collaborative Research Program</title><link>https://investorshangout.com/post/view?id=5396609</link><guid>https://investorshangout.com/post/view?id=5396609</guid><description><![CDATA[whytestocks
]]></description><pubDate>Fri, 29 Mar 2019 15:10:41 GMT</pubDate></item><item><title>whytestocks: $ATNM News Article - Actinium Highlights its Participation at the Upcoming Targeted Alpha Therapy In</title><link>https://investorshangout.com/post/view?id=5392676</link><guid>https://investorshangout.com/post/view?id=5392676</guid><description><![CDATA[whytestocks
]]></description><pubDate>Tue, 26 Mar 2019 15:10:44 GMT</pubDate></item><item><title>znewcar1: 16.07% v4,459,709 c.650000 f115,703,044 late afternoon vol</title><link>https://investorshangout.com/post/view?id=5356427</link><guid>https://investorshangout.com/post/view?id=5356427</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 20 Feb 2019 21:55:40 GMT</pubDate></item><item><title>znewcar1: 19% 5.9M C.6925 yesterday found support @.576</title><link>https://investorshangout.com/post/view?id=5098377</link><guid>https://investorshangout.com/post/view?id=5098377</guid><description><![CDATA[znewcar1
]]></description><pubDate>Wed, 20 Jun 2018 20:45:42 GMT</pubDate></item><item><title>znewcar1: 25% 6.6M C.6279</title><link>https://investorshangout.com/post/view?id=5093993</link><guid>https://investorshangout.com/post/view?id=5093993</guid><description><![CDATA[znewcar1
]]></description><pubDate>Mon, 18 Jun 2018 20:06:12 GMT</pubDate></item><item><title>arbo99: As a new investor in ATNM I have done a great deal of DD. It seems their biggest problem has been pa</title><link>https://investorshangout.com/post/view?id=4993212</link><guid>https://investorshangout.com/post/view?id=4993212</guid><description><![CDATA[arbo99
]]></description><pubDate>Thu, 05 Apr 2018 12:40:28 GMT</pubDate></item><item><title>2718: This Co will be over $9.00 by April</title><link>https://investorshangout.com/post/view?id=4777559</link><guid>https://investorshangout.com/post/view?id=4777559</guid><description><![CDATA[2718
]]></description><pubDate>Wed, 04 Oct 2017 18:21:49 GMT</pubDate></item><item><title>2718: We can HOPE for an 8k this am.Abstracts truly need to be NEW</title><link>https://investorshangout.com/post/view?id=4736520</link><guid>https://investorshangout.com/post/view?id=4736520</guid><description><![CDATA[2718
]]></description><pubDate>Thu, 14 Sep 2017 08:48:03 GMT</pubDate></item><item><title>2718: Armistice is SHORT w&#039; all those new shiny 4M shares along w&#039; KCG &amp; CDEL. Question is do they just e</title><link>https://investorshangout.com/post/view?id=4694736</link><guid>https://investorshangout.com/post/view?id=4694736</guid><description><![CDATA[2718
]]></description><pubDate>Sat, 12 Aug 2017 20:39:17 GMT</pubDate></item><item><title>BooDog: Shelf registration filed. A buying opportunity imo. We should be seeing the 10-Q very soon as well</title><link>https://investorshangout.com/post/view?id=4677795</link><guid>https://investorshangout.com/post/view?id=4677795</guid><description><![CDATA[BooDog
]]></description><pubDate>Fri, 28 Jul 2017 10:43:48 GMT</pubDate></item><item><title>BooDog: $ATNM just may have found its support for the bounce.</title><link>https://investorshangout.com/post/view?id=4676713</link><guid>https://investorshangout.com/post/view?id=4676713</guid><description><![CDATA[BooDog
]]></description><pubDate>Thu, 27 Jul 2017 14:12:54 GMT</pubDate></item><item><title>Teej: Trev4 from twits. Gonna hang a hat here. Left ihub cause it was full of numbskulls 2 years ago. Join</title><link>https://investorshangout.com/post/view?id=4668266</link><guid>https://investorshangout.com/post/view?id=4668266</guid><description><![CDATA[Teej
]]></description><pubDate>Thu, 20 Jul 2017 23:45:25 GMT</pubDate></item><item><title>BooDog: A little pre market action teasing here.</title><link>https://investorshangout.com/post/view?id=4652700</link><guid>https://investorshangout.com/post/view?id=4652700</guid><description><![CDATA[BooDog
]]></description><pubDate>Tue, 11 Jul 2017 12:16:44 GMT</pubDate></item><item><title>BooDog: Gap filled from February.</title><link>https://investorshangout.com/post/view?id=4605071</link><guid>https://investorshangout.com/post/view?id=4605071</guid><description><![CDATA[BooDog
]]></description><pubDate>Wed, 14 Jun 2017 15:54:31 GMT</pubDate></item><item><title>BooDog: Showing breakout potential. As well as SYN.</title><link>https://investorshangout.com/post/view?id=4587112</link><guid>https://investorshangout.com/post/view?id=4587112</guid><description><![CDATA[BooDog
]]></description><pubDate>Sat, 03 Jun 2017 17:14:56 GMT</pubDate></item><item><title>BooDog: Event: Hematologic Malignancies: New Therapies and the Evolving Role of Transplant 2017, Chicago, Il</title><link>https://investorshangout.com/post/view?id=4415682</link><guid>https://investorshangout.com/post/view?id=4415682</guid><description><![CDATA[BooDog
]]></description><pubDate>Wed, 15 Mar 2017 19:22:34 GMT</pubDate></item></channel></rss>